Mensinger Mike 4
4 · Beta Bionics, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Mensinger Mike
Chief Product Officer
Transactions
- Award
Common Stock
[F1]2026-02-27+109,105→ 189,857 total - Sale
Common Stock
[F2][F3]2026-03-02$12.36/sh−1,064$13,153→ 188,793 total - Award
Employee Stock Option (right to buy)
[F4]2026-02-27+58,749→ 58,749 totalExercise: $12.63Exp: 2036-02-26→ Common Stock (58,749 underlying)
Footnotes (4)
- [F1]Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
- [F2]The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- [F3]The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026.
Signature
/s/ Stephen Feider, Attorney-in-Fact|2026-03-03